null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Drug Development for Cancer and Diabetes (A Path to 2030) - 9781774634936

List Price: $99.00
SKU:
9781774634936
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    K. Saravanan, Chukwuebuka Egbuna, Horne Iona Averal, S. Kannan, S. Elavarasi, Bir Bahadur
    Format:
    Paperback
    Pages:
    392
    Publisher:
    Apple Academic Press,CRC Press (February 28, 2022)
    Language:
    English
    ISBN-13:
    9781774634936
    Weight:
    22.625oz
    Dimensions:
    6.125" x 9.1875"
    File:
    TAYLORFRANCIS-TayFran_260405043614355-20260405.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $99.00
    As low as:
    $94.05
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Case Pack:
    1
    Pub Discount:
    30
    Audience:
    College/higher education
    Country of Origin:
    United States
    Imprint:
    Apple Academic Press
  • Overview

    Key features include:







    • Details the role of plants for the treatment and management of cancer and diabetes






    • Discusses the role of phytocompounds as ligands for cancer and diabetic targets






    • Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs






    • Explores the green biosynthesis of nanoparticles and their treatment efficiency